Local delivery of antimicrobial peptides using self-organized TiO 2 nanotube arrays for peri-implant infections

Journal of Biomedical Materials Research - Part A

Volumn 100 A, Issue 2, 2012, Pages 278-285

  Ma, Menghan ^a   Kazemzadeh Narbat, Mehdi ^a   Hui, Yu ^a   Lu, Shanshan ^a   Ding, Chuanfan ^b   Chen, David D Y ^a   Hancock, Robert E W ^a   Wang, Rizhi ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b FUDAN UNIVERSITY   (China)

Author keywords

anodization; antimicrobial peptide; orthopaedic implants; peri implant infection; TiO 2 nanotubes

Indexed keywords

ANODIZATIONS; ANTIMICROBIAL PEPTIDE; ORTHOPAEDIC IMPLANTS; PERI-IMPLANT INFECTIONS; TIO;

ADSORPTION; ANTIBIOTICS; BACTERIA; BIOMATERIALS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PEPTIDES; POLYPEPTIDES; SURFACE STRUCTURE; SURFACE TESTING; TITANIUM; TITANIUM DIOXIDE;

NANOTUBES;

HHC 36; LYSYLARGINYLTRYPTOPHYLTRYPTOPHYLLYSYLTRYPTOPHYLTRYPTOPHYLARGINYLARGININE; NANOMATERIAL; NANOTUBE; POLYPEPTIDE ANTIBIOTIC AGENT; TITANIUM DIOXIDE; UNCLASSIFIED DRUG; ANTIMICROBIAL CATIONIC PEPTIDE; TITANIUM;

ADSORPTION; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DEVICE INFECTION; DRUG DELIVERY SYSTEM; ELUTION; GRAM POSITIVE BACTERIUM; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; ORTHOPEDIC PROSTHESIS; STAPHYLOCOCCUS AUREUS; AMINO ACID SEQUENCE; BACTERIAL COUNT; BACTERIUM ADHERENCE; CHEMISTRY; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; MICROBIAL SENSITIVITY TEST; MOLECULAR GENETICS; PROSTHESIS-RELATED INFECTIONS; RAMAN SPECTROMETRY; ULTRASTRUCTURE;

AMINO ACID SEQUENCE; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL ADHESION; COLONY COUNT, MICROBIAL; DRUG DELIVERY SYSTEMS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; NANOTUBES; PROSTHESIS-RELATED INFECTIONS; SPECTRUM ANALYSIS, RAMAN; STAPHYLOCOCCUS AUREUS; TITANIUM;

EID: 84655170097     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.33251     Document Type: Article

References (57)

1. Mariani BD, Tuan RS,. Advances in the diagnosis of infection in prosthetic joint implants. Mol Med Today 1998; 4: 207-213. (Pubitemid 28255551)
2. Bozic KJ, Kurtz SM, Lau E, Ong K, Vail TP, Berry DJ,. The epidemiology of revision total hip arthroplasty in the United States. J Bone Joint Surg Am 2009; 91: 128-133.
3. Goldhahn J, Suhm N, Goldhahn S, Blauth M, Hanson B,. Influence of osteoporosis on fracture fixation-A systematic literature review. Osteoporosis Int 2008; 19: 761-772.
4. Canadian Institute for Health Information, Hip and Knee Replacements in Canada-Canadian Joint Replacement Registry (CJRR) 2008-2009 Annual Report (Ottawa, Ontario: CIHI, 2009).
5. Campoccia D, Montanaro L, Arciola CR,. The significance of infection related to orthopedic devices and issues of antibiotic resistance. Biomaterials 2006; 27: 2331-2339. (Pubitemid 41821812)
6. Antoci V, Jr, Adams CS, Parvizi J, Davidson HM, Composto RJ, Freeman TA, Wickstrom E, Ducheyne P, Jungkind D, Shapiro IM, Hickok NJ,. The inhibition of Staphylococcus epidermidis biofilm formation by vancomycin-modified titanium alloy and implications for the treatment of periprosthetic infection. Biomaterials 2008; 29: 4684-4690.
7. Antoci V, Jr, King SB, Jose B, Parvizi J, Zeiger AR, Wickstrom E, Freeman TA, Composto RJ, Ducheyne P, Shapiro IM, Hickok NJ, Adams CS,. Vancomycin covalently bonded to titanium alloy prevents bacterial colonization. J Orthop Res 2007; 25: 858-866. (Pubitemid 47046432)
8. Zilberman M, Elsner JJ,. Antibiotic-eluting medical devices for various applications. J Control Release 2008; 130: 202-215.
9. Sia IG, Berbari EF, Karchmer AW,. Prosthetic joint infections. Infect Dis Clin North Am 2005; 19: 885-914. (Pubitemid 41627496)
10. Ewald A, Glueckermann SK, Thull R, Gbureck U,. Antimicrobial titanium/silver PVD coatings on titanium. Biomed Eng Online 2006; 5: 22.
11. Sculco TP,. The economic-impact of infected joint arthroplasty. Orthopedics 1995; 18: 871-873.
12. Lentino JR,. Prosthetic joint infections: Bane of orthopedists, challenge for infectious disease specialists. Clin Infect Dis 2003; 36: 1157-1161. (Pubitemid 36549638)
13. Trampuz A, Osmon DR, Hanssen AD, Steckelberg JM, Patel R,. Molecular and antibiofilm approaches to prosthetic joint infection. Clin Orthop Relat Res 2003: 69-88. (Pubitemid 37102138)
14. Trampuz A, Zimmerli W,. Prosthetic joint infections: Update in diagnosis and treatment. Swiss Med Wkly 2005; 135: 243-251. (Pubitemid 40769561)
15. Schmalzried TP, Amstutz HC, Au MK, Dorey FJ,. Etiology of deep sepsis in total hip-arthroplasty-The significance of hematogenous and recurrent infections. Clin Orthop Relat Res 1992: 200-207.
16. Zhao L, Chu PK, Zhang Y, Wu Z,. Antibacterial coatings on titanium implants. J Biomed Mater Res B Appl Biomater 2009; 91: 470-480.
17. Darouiche RO,. Current concepts-Treatment of infections associated with surgical implants. N Engl J Med 2004; 350: 1422-1429. (Pubitemid 38419996)
18. Costerton JW, Stewart PS, Greenberg EP,. Bacterial biofilms: A common cause of persistent infections. Science 1999; 284: 1318-1322. (Pubitemid 29289651)
19. Kazemzadeh-Narbat M, Kindrachuk J, Duan K, Jenssen H, Hancock REW, Wang R,. Antimicrobial peptides on calcium phosphate-coated titanium for the prevention of implant-associated infections. Biomaterials 2010; 31: 9519-9526.
20. Jenssen H, Hamill P, Hancock REW,. Peptide antimicrobial agents. Clin Microbiol Rev 2006; 19: 491-511. (Pubitemid 44137212)
21. Mookherjee N, Hancock REW,. Cationic host defence peptides: Innate immune regulatory peptides as a novel approach for treating infections. Cell Mol Life Sci 2007; 64: 922-933. (Pubitemid 46597762)
22. Hilpert K, Elliott MR, Volkmer-Engert R, Henklein P, Donini O, Zhou Q, Winkler DF, Hancock RE,. Sequence requirements and an optimization strategy for short antimicrobial peptides. Chem Biol 2006; 13: 1101-1107. (Pubitemid 44557074)
23. Cherkasov A, Hilpert K, Jenssen H, Fjell CD, Waldbrook M, Mullaly SC, Volkmer R, and, Hancock RE,. Use of artificial intelligence in the design of small peptide antibiotics effective against a broad spectrum of highly antibiotic-resistant superbugs. ACS Chem Biol 2009; 4: 65-74.
24. Hilpert K, Volkmer-Engert R, Walter T, Hancock REW,. High-throughput generation of small antibacterial peptides with improved activity. Nat Biotechnol 2005; 23: 1008-1012. (Pubitemid 41114036)
25. Moskowitz JS, Blaisse MR, Samuel RE, Hsu H, Harris MB, Martin SD, Lee JC, Spector M, Hammond PT,. The effectiveness of the controlled release of gentamicin from polyelectrolyte multilayers in the treatment of Staphylococcus aureus infection in a rabbit bone model. Biomaterials 2010; 31: 6019-6030.
26. Popat KC, Eltgroth M, LaTempa TJ, Grimes CA, Desai TA,. Decreased Staphylococcus epidermis adhesion and increased osteoblast functionality on antibiotic-loaded titania nanotubes. Biomaterials 2007; 28: 4880-4888. (Pubitemid 47285337)
27. 2 nanotubes: self-organized electrochemical formation, properties and applications. Curr Opin Solid State Mater Sci 2007; 11: 3-18. (Pubitemid 351758854)
28. Kim SE, Lim JH, Lee SC, Nam S, Kang H, Choi J,. Anodically nanostructured titanium oxides for implant applications. Electrochim Acta 2008; 53: 4846-4851.
29. Losic D, Simovic S,. Self-ordered nanopore and nanotube platforms for drug delivery applications. Expert Opin Drug Deliv 2009; 6: 1363-1381.
30. 2 nanotube layers. Electrochem Commun 2005; 7: 1066-1070. (Pubitemid 41360168)
31. Vasilev K, Poh Z, Kant K, Chan J, Michelmore A, Losic D,. Tailoring the surface functionalities of titania nanotube arrays. Biomaterials 2010; 31: 532-540.
32. 2 nanotube film with patterned wettability. Chem Commun 2009: 7018-7020.
33. Oh S, Daraio C, Chen LH, Pisanic TR, Finones RR, Jin S,. Significantly accelerated osteoblast cell growth on aligned TiO2 nanotubes. J Biomed Mater Res A 2006; 78: 97-103. (Pubitemid 44032531)
34. Bjursten LM, Rasmusson L, Oh S, Smith GC, Brammer KS, Jin S,. Titanium dioxide nanotubes enhance bone bonding in vivo. J Biomed Mater Res A 2010; 92: 1218-1224.
35. Brammer KS, Oh S, Cobb CJ, Bjursten LM, Van der Heyde H, Jin S,. Improved bone-forming functionality on diameter-controlled TiO2 nanotube surface. Acta Biomater 2009; 5: 3215-3223.
36. 2 nanotubes: An experimental study in the pig. J Biomed Mater Res B Appl Biomater 2009; 89: 165-171.
37. 2 nanotubes. Nano Lett 2009; 9: 1932-1936.
38. Popat KC, Eltgroth M, La Tempa TJ, Grimes CA, Desai TA,. Titania nanotubes: A novel platform for drug-eluting coatings for medical implants? Small 2007; 3: 1878-1881. (Pubitemid 350099856)
39. 2 nanotubes. Phys Status Solidi-Rapid Res Lett 2007; 1: 181-183. (Pubitemid 351175920)
40. 2 nanotubes. J Phys Chem C 2009; 113: 12759-12765.
41. 2 nanotubes in viscous electrolytes. Electrochim Acta 2006; 52: 1258-1264. (Pubitemid 44550109)
42. 2 nanotubes: Phase composition and chemical composition. Surf Interface Anal 2010; 42: 139-144.
43. 2 Nanotubes: Synthesis, Growth Mechanism and Thermal Stability. PhD Thesis. University of Bath: Bath, UK; 2008.
44. Hilpert K, Elliott M, Jenssen H, Kindrachuk J, Fjell CD, Koerner J, Winkler DFH, Weaver LL, Henklein P, Ulrich AS, Chiang SHY, Farmer SW, Pante N, Volkmer R, Hancock REW,. Screening and characterization of surface-tethered cationic peptides for antimicrobial activity. Chem Biol 2009; 16: 58-69.
45. Zwilling V, Darque-Ceretti E, Boutry-Forveille A, David D, Perrin MY, Aucouturier M,. Structure and physicochemistry of anodic oxide films on titanium and TA6V alloy. Surf Interface Anal 1999; 27: 629-637. (Pubitemid 129585170)
46. 2 nanotube array growth by anodization. J Phys Chem C 2007; 111: 7235-7241. (Pubitemid 46915361)
47. Hetrick EM, Schoenfisch MH,. Reducing implant-related infections: Active release strategies. Chem Soc Rev 2006; 35: 780-789. (Pubitemid 44286273)
48. Wu P, Grainger DW,. Drug/device combinations for local drug therapies and infection prophylaxis. Biomaterials 2006; 27: 2450-2467. (Pubitemid 41821824)
49. 2. Biomaterials 1991; 12: 593-596.
50. 2 from single protein solutions and from plasma. Langmuir 2004; 20: 9745-9754.
51. Cacciafesta P, Humphris ADL, Jandt KD, Miles MJ,. Human plasma fibrinogen adsorption on ultraflat titanium oxide surfaces studied with atomic force microscopy. Langmuir 2000; 16: 8167-8175.
52. 2 films: An immobilization strategy for bioanalytical devices. Anal Chem 1998; 70: 5111-5113.
53. 2 nanotube films. Chemosphere 2008; 73: 805-812.
54. Wang N, Lin H, Li JB, Yang XZ, Chi B,. Electrophoretic deposition and optical property of titania nanotubes films. Thin Solid Films 2006; 496: 649-652. (Pubitemid 41693732)
55. 2 nanotubes. J Biomed Mater Res A 2006; 77: 534-541. (Pubitemid 47233578)
56. Uchida M, Kim HM, Kokubo T, Fujibayashi S, Nakamura T,. Structural dependence of apatite formation on titania gels in a simulated body fluid. J Biomed Mater Res A 2003; 64: 164-170. (Pubitemid 37521479)
57. 2 nanotube layers on titanium in Hank's solution. Biomed Mater 2009; 4: 065012.